| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Angina Pectoris | D000787 | 27 associated lipids |
| Edema | D004487 | 152 associated lipids |
Total
3
Tribehenin
Tribehenin is a lipid of Glycerolipids (GL) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Tribehenin
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Tribehenin
NCBI Entrez Crosslinks
All references with Tribehenin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Wong PC et al. | A study on the solid state characteristics of spray-congealed glyceryl dibehenate solid lipid microparticles containing ibuprofen. | 2016 | Drug Dev Ind Pharm | pmid:26079425 |
| Gu X et al. | Evaluation and comparison of five matrix excipients for the controlled release of acrivastine and pseudoephedrine. | 2004 | Drug Dev Ind Pharm | pmid:15595567 |
| Iloañusi NO and Schwartz JB | The effect of wax on compaction of microcrystalline cellulose beads made by extrusion and spheronization. | 1998 | Drug Dev Ind Pharm | pmid:15605595 |
| Roberts M et al. | Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets. | 2012 | Drug Dev Ind Pharm | pmid:22149472 |
| Stanisz B et al. | Effect of pharmaceutical excipients on the stability of angiotensin-converting enzyme inhibitors in their solid dosage formulations. | 2013 | Drug Dev Ind Pharm | pmid:22348774 |
| Yang R et al. | The influence of lipid characteristics on the formation, in vitro release, and in vivo absorption of protein-loaded SLN prepared by the double emulsion process. | 2011 | Drug Dev Ind Pharm | pmid:20578879 |
| Punyamurthula NS et al. | Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol. | 2016 | Drug Dev Ind Pharm | pmid:26585693 |
| Scalia S and Mezzena M | Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. | 2009 | Drug Dev Ind Pharm | pmid:18785040 |
| Zhang YE and Schwartz JB | Melt granulation and heat treatment for wax matrix-controlled drug release. | 2003 | Drug Dev Ind Pharm | pmid:12648009 |
| Mirghani A et al. | Formulation and release behavior of diclofenac sodium in Compritol 888 matrix beads encapsulated in alginate. | 2000 | Drug Dev Ind Pharm | pmid:10872101 |